 | • レポートコード：TPM-B04554 • 出版社/出版日：Transparency Market Research / 2017年10月 • レポート形態：英文、PDF、280ページ • 納品方法：Eメール • 産業分類：医療 |
| Single User | ￥857,660 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,301,660 (USD8,795) | ▷ お問い合わせ |
| Global Site License | ￥1,745,660 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本資料は、デジタル治療機器の世界市場について調べ、デジタル治療機器の世界規模、市場動向、市場環境、製品別分析、用途別分析、最終用途別分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。 ・序文・調査範囲・調査手法 ・エグゼクティブサマリー ・デジタル治療機器の世界市場動向 ・デジタル治療機器の世界市場環境 ・デジタル治療機器の世界市場規模 ・デジタル治療機器の世界市場規模：製品別 ・デジタル治療機器の世界市場規模：用途別 ・デジタル治療機器の世界市場規模：最終用途別 ・デジタル治療機器の世界市場：地域別市場規模・分析 ・デジタル治療機器の北米市場規模・予測 ・デジタル治療機器のアメリカ市場規模・予測 ・デジタル治療機器の中南米市場規模・予測 ・デジタル治療機器のヨーロッパ市場規模・予測 ・デジタル治療機器のアジア市場規模・予測 ・デジタル治療機器の日本市場規模・予測 ・デジタル治療機器の中国市場規模・予測 ・デジタル治療機器の中東市場規模・予測 ・デジタル治療機器のアフリカ市場規模・予測 ・競争状況・関連企業情報 |
Global Digital Therapeutic Devices Market: Scope and Methodology
This report on the global digital therapeutic devices market analyzes the current and future prospects of the market. The report comprises an elaborate executive summary, including a market snapshot that provides overall information of various segments and sub-segments.
The research is a combination of primary and secondary research. Primary research formed the bulk of our research efforts along with information collected from telephonic interviews and interactions via e-mails. Secondary research involved study of company websites, annual reports, press releases, stock analysis presentations, and various international and national databases. The report provides market size in terms of US$ Mn for each segment for the period from 2015 to 2025, considering the macro and micro environmental factors. Growth rates for each segment within the global digital therapeutic devices market have been determined after a thorough analysis of past trends, demographics, future trends, technological developments, and regulatory requirements.
A detailed qualitative analysis of factors responsible for driving and restraining market growth and future opportunities has been provided in the market overview section. This section of the report also includes market attractiveness analysis that provides a thorough analysis of the overall competitive scenario in the global digital therapeutic devices market.
Market revenue in terms of US$ Mn for the period between 2015 and 2025 along with the compound annual growth rate (CAGR %) from 2017 to 2025 are provided for all the segments, considering 2016 as the base year. Market size estimations involved in-depth study of services and product features of different types of services. Additionally, market related factors such as increasing preference for technologically advanced services, product innovation, and increasing prevalence of diabetes and other chronic diseases in various geographies and historical year-on-year growth have been taken into consideration while estimating the market size.
Digital Therapeutic Devices Market: Segmentation
Based on product, the global digital therapeutic devices market has been segmented into pain management devices, rehabilitation devices, respiratory therapy devices and insulin pumps. Based on application, the digital therapeutic devices market is segmented into preventive, treatment/care. Preventive application is further segmented into pre diabetes, obesity, smoking cessation and others. Treatment/care application is further categorized into diabetes, cardiovascular diseases, central nervous system disease, respiratory diseases, musculoskeletal diseases, medication adherence and others. Based on end user, the digital therapeutic devices market is segmented into B2C and B2B. B2C end user is further segmented into patients and caregivers and B2B is further classified into providers, payers, employers, pharmaceutical companies and others.
Digital Therapeutic Devices Market: Geographical and Competitive Dynamics
Geographically, the global digital therapeutic devices market has been segmented into six regions: North America, Europe, Asia Pacific, Latin America, Middle East and Africa. In addition, the regions have been further segmented by major countries from each region. These include the U.S., Canada, the U.K., Germany, France, Italy, Spain, China, and Japan.
The report also profiles major players in the digital therapeutic devices market based on various attributes such as company overview, financial overview, SWOT analysis, key business strategies, product portfolio, and recent developments. Key companies profiled in the report include Proteus Digital Therapeutic Devices, Omada Health, Inc., WellDoc, Inc., Livongo Health, Noom, Inc., Ginger.io, Inc., Propeller Health, 2Morrow, Inc., Canary Health, Mango Health, BiogeniQ Inc., Twine Health, Inc., Glooko, Inc., Firstbeat Technologies Ltd, Claritas MindSciences, Big Health, Nanobiosym, Inc., Dthera Sciences, Jintronix, Inc., Virta Health Corp, Zest Health, LLC, Meru Health, Inc., HealthMine, Inc., Pear Therapeutics, Inc., BioTelemetry, Inc., Blue Mesa Health, and Digital Therapeutics.
The global digital therapeutic devices market has been segmented as follows:
Global Digital Therapeutic Devices Market, by Product
Pain Management Devices
Rehabilitation Devices
Respiratory Therapy Devices
Insulin Pumps
Global Digital Therapeutic Devices Market, by Application
Preventive
Pre diabetes
Obesity
Smoking Cessation
Others
Treatment/Care
Diabetes
Cardiovascular Diseases
Central Nervous System Disease
Respiratory Diseases
Musculoskeletal Diseases
Medication Adherence
Others
Global Digital Therapeutic Devices Market, by End User
B2C
Patients
Caregivers
B2B
Providers
Payers
Employers
Pharmaceutical Companies
Others
Global Digital Therapeutic Devices Market, by Geography
North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
Rest of Asia Pacific
Latin America
Middle East & Africa
Section 1 Preface
1.1 Report Scope and Market Segmentation
1.2 Research Highlights
Section 2 Assumptions and Research Methodology
2.1 Research Methodology
Section 3 Executive Summary
3.1 Global Digital Therapeutic Devices Market Snapshot
3.2 Global Digital Therapeutic Devices Market Size ($ Mn) and Distribution, by Geography, 2017 and 2025
Section 4 Market Overview
4.1 Overview
4.2 Global Digital Therapeutic Devices Market: Porter’s Analysis
4.3 Global Digital Therapeutic Devices Market Size (US$ Mn) Forecast, 2015–2025
4.4 Global Digital Therapeutic Devices Market Outlook
Section 5 Market Dynamic
5.1 Drivers
5.1.1 Increasing Government Initiatives
5.1.2 Strategic Acquisitions enable Product Distribution in Other Regions, and also strengthening their Presence
5.1.3 Rising incidence of Diabetes, Cardiovascular Diseases and other Chronic Diseases
5.1.4 Increasing Collaborations between Companies for Technological Advancements
5.1.5 Increasing Adoption of Digital Therapeutic Devices Product by Health Care Providers
5.2 Restrains
5.2.1 High Costs Associated with Installation
5.2.2 Cyber Threat
5.3 Opportunities
5.3.1 Adoption of cloud-based systems by health care organization and hospitals
5.3.2 Penetration of smartphones in the health care sector & increase in demand for mobile apps
5.4 Trends
5.4.1 Increasing adoption of cloud-based systems
5.4.2 Virtualization technologies and technological advancements add new dimension to health care IT
5.5 Digital Therapeutics Business, Opportunities and Entry Barriers for New Market Entrants – 2016
5.6 Qualitative Information on Business Models in Digital Therapeutic Devices Market
5.7 Traditional Business Models: Challenges to Traditional Business models
5.8 New Digital Therapeutic Devices Business Models
5.9 Adoption of Digital Therapeutic Devicescare by End-users
5.10 Impact Factors for Digital Therapeutics Demand
5.11 Global Health Care Expenditure, by Major Countries
5.12 Digital Medicine Business Model
5.13 Factors Increasing Traction of Digital Therapeutics Products
5.13.1 Health Care Costs
5.13.2 Value-based Payment Models
5.13.3 Venture Funding
5.13.4 Others
Section 6 Global Digital Therapeutic Devices Market Analysis, by Product
6.1 Introduction
6.2 Global Digital Therapeutic Devices Market Value Share Analysis, by Product
6.3 Digital Therapeutic Devices Market Analysis, by Product
6.3.1 Pain management devices
6.3.2 Rehabilitation devices
6.3.3 Respiratory therapy devices
6.3.4 Insulin Pumps
6.4 Global Digital Therapeutic Devices Market Attractiveness Analysis, by Product
Section 7 Global Digital Therapeutic Devices (Digital Therapeutic Devices) Market Analysis, by Application
7.1 Introduction
7.2 Global Digital Therapeutic Devices (Digital Therapeutic Devices) Market Value Share Analysis, by Application
7.3 Global Digital Therapeutic Devices (Digital Therapeutic Devices) Market Analysis, by Application
7.3.1 Preventive
7.3.1.1 Pre diabetes
7.3.1.2 Obesity
7.3.1.3 Smoking Cessation
7.3.1.4 Others
7.3.2 Treatment/Care
7.3.2.1 Diabetes
7.3.2.2 Cardiovascular Diseases
7.3.2.3 Central Nervous System Disease
7.3.2.4 Respiratory Diseases
7.3.2.5 Musculoskeletal Diseases
7.3.2.6 Medication Adherence
7.3.2.7 Others
Section 8 Global Digital Therapeutic Devices Market Analysis, by End-user
8.1 Introduction
8.2 Global Digital Therapeutic Devices Market Value Share Analysis, by End-user
8.3 Global Digital Therapeutic Devices Market Analysis, by End-user
8.3.1 B2C
8.3.1.1 Patients
8.3.1.2 Caregivers
8.3.2 B2B
8.3.2.1 Providers
8.3.2.2 Payers
8.3.2.3 Employers
8.3.2.4 Pharmaceutical Companies
8.3.2.5 Others
8.4 Global Digital Therapeutic Devices Market Attractiveness Analysis, by End-user
Section 9 Global Digital Therapeutic Devices Market Analysis, by Region
9.1 Global Digital Therapeutic Devices Market Snapshot, by Country
9.2 Global Digital Therapeutic Devices Market Value Share Analysis, by Region
9.3 Digital Therapeutic Devices Market Forecast, by Region
9.4 Digital Therapeutic Devices Market Attractiveness Analysis, by Region
Section 10 North America Digital Therapeutic Devices Market Analysis
10.1 Key Findings
10.2 North America Digital Therapeutic Devices Market Overview
10.3 North America Digital Therapeutic Devices Market Value Share Analysis, by Product
10.4 North America Market Size (US$ Mn) Forecast, by Product, 2017–2025
10.4.1 Pain management devices
10.4.2 Rehabilitation devices
10.4.3 Respiratory therapy devices
10.4.4 Insulin Pumps
10.5 North America Digital Therapeutic Devices (Digital Therapeutic Devices) Market Value Share Analysis, by Application
10.6 North America Market Size (US$ Mn) Forecast, by Application (Digital Therapeutic Devices) 2017–2025
10.6.1 Preventive
10.6.1.1 Pre diabetes
10.6.1.2 Obesity
10.6.1.3 Smoking Cessation
10.6.1.4 Others
10.6.2 Treatment/Care
10.6.2.1 Diabetes
10.6.2.2 Cardiovascular Diseases
10.6.2.3 Central Nervous System Disease
10.6.2.4 Respiratory Diseases
10.6.2.5 Musculoskeletal Diseases
10.6.2.6 Medication Adherence
10.6.2.7 Others
10.7 North America Digital Therapeutic Devices Market Value Share Analysis, by End-user
10.8 North America Market Size (US$ Mn) Forecast, by End-user 2017–2025
10.8.1 B2C
10.8.1.1 Patients
10.8.1.2 Caregivers
10.8.2 B2B
10.8.2.1 Providers
10.8.2.2 Payers
10.8.2.3 Employers
10.8.2.4 Pharmaceutical Companies
10.8.2.5 Others
10.9 North America Market Value Share Analysis, by Country
10.10 North America Market Size (US$ Mn) Forecast, by Country, 2017–2025
10.10.1 U.S.
10.10.2 Canada
10.11 Market Attractiveness Analysis
10.11.1 By Product
10.11.2 By Application
10.11.3 By End User
10.11.4 By Country
Section 11 Europe Digital Therapeutic Devices Market Analysis
11.1 Key Findings
11.2 Europe Digital Therapeutic Devices Market Overview
11.3 Europe Digital Therapeutic Devices Market Value Share Analysis, by Product
11.4 Europe Market Size (US$ Mn) Forecast, by Product, 2017–2025
11.4.1 Pain management devices
11.4.2 Rehabilitation devices
11.4.3 Respiratory therapy devices
11.4.4 Insulin Pumps
11.5 Europe Digital Therapeutic Devices (Digital Therapeutic Devices) Market Value Share Analysis, by Application
11.6 Europe Market Size (US$ Mn) Forecast, by Application (Digital Therapeutic Devices) 2017–2025
11.6.1 Preventive
11.6.1.1 Pre diabetes
11.6.1.2 Obesity
11.6.1.3 Smoking Cessation
11.6.1.4 Others
11.6.2 Treatment/Care
11.6.2.1 Diabetes
11.6.2.2 Cardiovascular Diseases
11.6.2.3 Central Nervous System Disease
11.6.2.4 Respiratory Diseases
11.6.2.5 Musculoskeletal Diseases
11.6.2.6 Medication Adherence
11.6.2.7 Others
11.7 Europe Digital Therapeutic Devices Market Value Share Analysis, by End-user
11.8 Europe Market Size (US$ Mn) Forecast, by End-user 2017–2025
11.8.1 B2C
11.8.1.1 Patients
11.8.1.2 Caregivers
11.8.2 B2B
11.8.2.1 Providers
11.8.2.2 Payers
11.8.2.3 Employers
11.8.2.4 Pharmaceutical Companies
11.8.2.5 Others
11.9 Europe Market Value Share Analysis, by Country
11.10 Europe Market Size (US$ Mn) Forecast, by Country, 2017–2025
11.10.1 U.K.
11.10.2 Germany
11.10.3 France
11.10.4 Italy
11.10.5 Spain
11.10.6 Rest of Europe
11.11 Market Attractiveness Analysis
11.11.1 By Product
11.11.2 By Application
11.11.3 By End User
11.11.4 By Country
Section 12 Asia Pacific Digital Therapeutic Devices Market Analysis
12.1 Key Findings
12.2 Asia Pacific Digital Therapeutic Devices Market Overview
12.3 Asia Pacific Digital Therapeutic Devices Market Value Share Analysis, by Product
12.4 Asia Pacific Market Size (US$ Mn) Forecast, by Product, 2017–2025
12.4.1 Pain management devices
12.4.2 Rehabilitation devices
12.4.3 Respiratory therapy devices
12.4.4 Insulin Pumps
12.5 Asia Pacific Digital Therapeutic Devices (Digital Therapeutic Devices) Market Value Share Analysis, by Application
12.6 Asia Pacific Market Size (US$ Mn) Forecast, by Application (Digital Therapeutic Devices) 2017–2025
12.6.1 Preventive
12.6.1.1 Pre diabetes
12.6.1.2 Obesity
12.6.1.3 Smoking Cessation
12.6.1.4 Others
12.6.2 Treatment/Care
12.6.2.1 Diabetes
12.6.2.2 Cardiovascular Diseases
12.6.2.3 Central Nervous System Disease
12.6.2.4 Respiratory Diseases
12.6.2.5 Musculoskeletal Diseases
12.6.2.6 Medication Adherence
12.6.2.7 Others
12.7 Asia Pacific Digital Therapeutic Devices Market Value Share Analysis, by End-user
12.8 Asia Pacific Market Size (US$ Mn) Forecast, by End-user 2017–2025
12.8.1 B2C
12.8.1.1 Patients
12.8.1.2 Caregivers
12.8.2 B2B
12.8.2.1 Providers
12.8.2.2 Payers
12.8.2.3 Employers
12.8.2.4 Pharmaceutical Companies
12.8.2.5 Others
12.9 Asia Pacific Market Value Share Analysis, by Country
12.10 Asia Pacific Market Size (US$ Mn) Forecast, by Country, 2017–2025
12.10.1 China
12.10.2 Japan
12.10.3 Rest of Asia Pacific
12.11 Market Attractiveness Analysis
12.11.1 By Product
12.11.2 By Application
12.11.3 By End User
12.11.4 By Country
Section 13 Latin America Digital Therapeutic Devices Market Analysis
13.1 Key Findings
13.2 Latin America Digital Therapeutic Devices Market Overview
13.3 Latin America Digital Therapeutic Devices Market Value Share Analysis, by Product
13.4 Latin America Market Size (US$ Mn) Forecast, by Product, 2017–2025
13.4.1 Pain management devices
13.4.2 Rehabilitation devices
13.4.3 Respiratory therapy devices
13.4.4 Insulin Pumps
13.5 Latin America Digital Therapeutic Devices (Digital Therapeutic Devices) Market Value Share Analysis, by Application
13.6 Latin America Market Size (US$ Mn) Forecast, by Application (Digital Therapeutic Devices) 2017–2025
13.6.1 Preventive
13.6.1.1 Pre diabetes
13.6.1.2 Obesity
13.6.1.3 Smoking Cessation
13.6.1.4 Others
13.6.2 Treatment/Care
13.6.2.1 Diabetes
13.6.2.2 Cardiovascular Diseases
13.6.2.3 Central Nervous System Disease
13.6.2.4 Respiratory Diseases
13.6.2.5 Musculoskeletal Diseases
13.6.2.6 Medication Adherence
13.6.2.7 Others
13.7 Latin America Digital Therapeutic Devices Market Value Share Analysis, by End-user
13.8 Latin America Market Size (US$ Mn) Forecast, by End-user 2017–2025
13.8.1 B2C
13.8.1.1 Patients
13.8.1.2 Caregivers
13.8.2 B2B
13.8.2.1 Providers
13.8.2.2 Payers
13.8.2.3 Employers
13.8.2.4 Pharmaceutical Companies
13.8.2.5 Others
13.9 Market Attractiveness Analysis
13.9.1 By Product
13.9.2 By Application
13.9.3 By End User
Section 14 Middle East & Africa Digital Therapeutic Devices Market Analysis
14.1 Key Findings
14.2 Middle East & Africa Digital Therapeutic Devices Market Overview
14.3 Middle East & Africa Digital Therapeutic Devices Market Value Share Analysis, by Product
14.4 Middle East & Africa Market Size (US$ Mn) Forecast, by Product, 2017–2025
14.4.1 Pain management devices
14.4.2 Rehabilitation devices
14.4.3 Respiratory therapy devices
14.4.4 Insulin Pumps
14.5 Middle East & Africa Digital Therapeutic Devices (Digital Therapeutic Devices) Market Value Share Analysis, by Application
14.6 Middle East & Africa Market Size (US$ Mn) Forecast, by Application (Digital Therapeutic Devices) 2017–2025
14.6.1 Preventive
14.6.1.1 Pre diabetes
14.6.1.2 Obesity
14.6.1.3 Smoking Cessation
14.6.1.4 Others
14.6.2 Treatment/Care
14.6.2.1 Diabetes
14.6.2.2 Cardiovascular Diseases
14.6.2.3 Central Nervous System Disease
14.6.2.4 Respiratory Diseases
14.6.2.5 Musculoskeletal Diseases
14.6.2.6 Medication Adherence
14.6.2.7 Others
14.7 Middle East & Africa Digital Therapeutic Devices Market Value Share Analysis, by End-user
14.8 Middle East & Africa Market Size (US$ Mn) Forecast, by End-user 2017–2025
14.8.1 B2C
14.8.1.1 Patients
14.8.1.2 Caregivers
14.8.2 B2B
14.8.2.1 Providers
14.8.2.2 Payers
14.8.2.3 Employers
14.8.2.4 Pharmaceutical Companies
14.8.2.5 Others
14.9 Market Attractiveness Analysis
14.9.1 By Product
14.9.2 By Application
14.9.3 By End User
Section 15 Company Profiles
15.1 Company Share Analysis
15.2 Company Profiles
15.2.1 Proteus Digital Therapeutic Devices
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Revenue Model
15.2.1.3. Product Portfolio
15.2.1.4. SWOT Analysis
15.2.1.5. Strategic Overview
15.2.1.6. Funding Overview
15.2.2 Omada Health, Inc.
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Revenue Model
15.2.2.3. Product Portfolio
15.2.2.4. SWOT Analysis
15.2.2.5. Strategic Overview
15.2.2.6. Funding Overview
15.2.3 WellDoc, Inc.
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. SWOT Analysis
15.2.3.4. Strategic Overview
15.2.4 Livongo Health
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. SWOT Analysis
15.2.4.4. Strategic Overview
15.2.4.5. Funding Overview
15.2.5 Noom, Inc.
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. SWOT Analysis
15.2.5.4. Strategic Overview
15.2.5.5. Funding Overview
15.2.6 Ginger.io, Inc.
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. SWOT Analysis
15.2.6.4. Strategic Overview
15.2.7 Propeller Health
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. SWOT Analysis
15.2.7.4. Strategic Overview
15.2.7.5. Funding Overview
15.2.8 2Morrow, Inc.
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Product Portfolio
15.2.8.3. SWOT Analysis
15.2.8.4. Strategic Overview
15.2.9 Canary Health
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Product Portfolio
15.2.9.3. SWOT Analysis
15.2.9.4. Strategic Overview
15.2.10 Mango Health
15.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.10.2. Product Portfolio
15.2.10.3. SWOT Analysis
15.2.10.4. Strategic Overview
15.2.10.5. Funding Overview
15.2.11 BiogeniQ Inc.
15.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.11.2. Product Portfolio
15.2.11.3. SWOT Analysis
15.2.11.4. Strategic Overview
15.2.12 Twine Health, Inc.
15.2.12.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.12.2. Product Portfolio
15.2.12.3. SWOT Analysis
15.2.12.4. Strategic Overview
15.2.13 Glooko, Inc.
15.2.13.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.13.2. Product Portfolio
15.2.13.3. SWOT Analysis
15.2.13.4. Strategic Overview
15.2.13.5. Funding Overview
15.2.14 Firstbeat Technologies Ltd
15.2.14.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.14.2. Product Portfolio
15.2.14.3. SWOT Analysis
15.2.14.4. Strategic Overview
15.2.15 Claritas MindSciences
15.2.15.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.15.2. Product Portfolio
15.2.15.3. SWOT Analysis
15.2.15.4. Strategic Overview
15.2.16 Big Health
15.2.16.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.16.2. Product Portfolio
15.2.16.3. SWOT Analysis
15.2.16.4. Strategic Overview
15.2.16.5. Revenue Model
15.2.17 Nanobiosym, Inc.
15.2.17.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.17.2. Product Portfolio
15.2.17.3. SWOT Analysis
15.2.17.4. Strategic Overview
15.2.18 Dthera Sciences
15.2.17.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.17.2. Financial Overview
15.2.17.3. Product Portfolio
15.2.17.4. SWOT Analysis
15.2.17.5. Strategic Overview
15.2.19 Jintronix, Inc.
15.2.19.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.19.2. Product Portfolio
15.2.19.3. SWOT Analysis
15.2.19.4. Strategic Overview
15.2.19.5. Funding Overview
15.2.20 Virta Health Corp
15.2.20.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.20.2. Product Portfolio
15.2.20.3. SWOT Analysis
15.2.20.4. Strategic Overview
15.2.21 Zest Health, LLC
15.2.21.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.21.2. Product Portfolio
15.2.21.3. SWOT Analysis
15.2.21.4. Strategic Overview
15.2.21.5. Funding Overview
15.2.22 Meru Health, Inc.
15.2.22.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.22.2. Product Portfolio
15.2.22.3. SWOT Analysis
15.2.22.4. Strategic Overview
15.2.22.5. Funding Overview
15.2.23 HealthMine, Inc.
15.2.23.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.23.2. Product Portfolio
15.2.23.3. SWOT Analysis
15.2.23.4. Strategic Overview
15.2.23.5. Funding Overview
15.2.24 Pear Therapeutics, Inc.
15.2.24.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.24.2. Product Portfolio
15.2.24.3. SWOT Analysis
15.2.24.4. Strategic Overview
15.2.24.5. Funding Overview
15.2.25 BioTelemetry, Inc.
15.2.25.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.25.2. Financial Overview
15.2.25.3. Product Portfolio
15.2.25.4. SWOT Analysis
15.2.25.5. Strategic Overview
15.2.26 Blue Mesa Health
15.2.27.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.27.2. Financial Overview
15.2.27.3. Product Portfolio
15.2.27.4. SWOT Analysis
15.2.27.5. Strategic Overview
15.2.27 Digital Therapeutics
15.2.27.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.27.2. Financial Overview
15.2.27.3. Product Portfolio
15.2.27.4. SWOT Analysis
15.2.27.5. Strategic Overview
15.3 M&A Deals – Digital Health
15.3.1 M&A Deals in the Digital Therapeutic Devices Market (2015)
15.3.2 M&A Deals in the Digital Therapeutic Devices Market (2016)
15.3.3 M&A Deals in the Digital Therapeutic Devices Market (2015)
15.4 Funding Deals – Digital Health
15.4.1 Funding Deals in the Digital Therapeutic Devices Market (2015)
15.4.2 Funding Deals in the Digital Therapeutic Devices Market (2016)
15.4.3 Funding Deals in the Digital Therapeutic Devices Market (2015)
Table 01: Diabetes Prevalence
Table 02: Data Security Breach
Table 03: Global Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 04: Global Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 05: Global Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Application (Preventive), 2015–2025
Table 06: Global Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Application (Treatment/Care),
Table 07: Global Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 08: Global B2C Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 09: Global B2B Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 10: Global Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 11: North America Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 12: North America Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 13: North America Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 14: North America Digital Therapeutic Devices Application Market Size (US$ Mn) Forecast, by Preventive, 2015–2025
Table 15: North America Digital Therapeutic Devices Application Market Size (US$ Mn) Forecast, by Treatment/Care, 2015–2025
Table 16: North America Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 17: North America Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user (B2C), 2015–2025
Table 18: North America Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user (B2B), 2015–2025
Table 19: Europe Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 20: Europe Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 21: Europe Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 22: Europe Digital Therapeutic Devices Application Market Size (US$ Mn) Forecast, by Preventive, 2015–2025
Table 23: Europe Digital Therapeutic Devices Application Market Size (US$ Mn) Forecast, by Treatment/Care, 2015–2025
Table 24: Europe Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 25: Europe Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user (B2C), 2015–2025
Table 26: Europe Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user (B2B), 2015–2025
Table 27: Asia Pacific Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 28: Asia Pacific Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 29: Asia Pacific Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 30: Asia Pacific Digital Therapeutic Devices Application Market Size (US$ Mn) Forecast, by Preventive, 2015–2025
Table 31: Asia Pacific Digital Therapeutic Devices Application Market Size (US$ Mn) Forecast, by Treatment/Care, 2015–2025
Table 32: Asia Pacific Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 33: Asia Pacific Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user (B2C), 2015–2025
Table 34: Asia Pacific Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user (B2B), 2015–2025
Table 35: Latin America Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 36: Latin America Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 37: Latin America Digital Therapeutic Devices Application Market Size (US$ Mn) Forecast, by Preventive, 2015–2025
Table 38: Latin America Digital Therapeutic Devices Application Market Size (US$ Mn) Forecast, by Treatment/Care, 2015–2025
Table 39: Latin America Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 40: Latin America Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user (B2C), 2015–2025
Table 41: Latin America Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user (B2B), 2015–2025
Table 42: Middle East & Africa Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Product, 2015–2025
Table 43: Middle East & Africa Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by Application, 2015–2025
Table 44: Middle East & Africa Digital Therapeutic Devices Application Market Size (US$ Mn) Forecast, by Preventive, 2015–2025
Table 45: Middle East & Africa Digital Therapeutic Devices Application Market Size (US$ Mn) Forecast, by Treatment/Care, 2015–2025
Table 46: Middle East & Africa Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 47: Middle East & Africa Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user (B2C), 2015–2025
Table 48: Middle East & Africa Digital Therapeutic Devices Market Size (US$ Mn) Forecast, by End-user (B2B), 2015–2025